{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:53:23Z","timestamp":1789588403505,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Shanghai Science and Technology Commission","award":["15411953200"],"award-info":[{"award-number":["15411953200"]}]},{"name":"Shanghai Science and Technology Commission","award":["10411956600"],"award-info":[{"award-number":["10411956600"]}]},{"name":"Shanghai Science and Technology Commission","award":["14ZR1427400"],"award-info":[{"award-number":["14ZR1427400"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300667"],"award-info":[{"award-number":["81300667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81000332"],"award-info":[{"award-number":["81000332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170322"],"award-info":[{"award-number":["81170322"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370953"],"award-info":[{"award-number":["81370953"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370935"],"award-info":[{"award-number":["81370935"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Health System Outstanding Young Talents Training Program","award":["XYQ2013098"],"award-info":[{"award-number":["XYQ2013098"]}]},{"name":"Shanghai Education Committee Key Program","award":["14zz110"],"award-info":[{"award-number":["14zz110"]}]},{"name":"State Key Development Program for Basic Research of China","award":["2012CB517501"],"award-info":[{"award-number":["2012CB517501"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.metabol.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T01:33:44Z","timestamp":1450488824000},"page":"475-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case\u2013control study in China"],"prefix":"10.1016","volume":"65","author":[{"given":"Yixin","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.12.005_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","article-title":"Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease","volume":"63","author":"Polyzos","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0010","doi-asserted-by":"crossref","first-page":"d3897","DOI":"10.1136\/bmj.d3897","article-title":"How big a problem is non-alcoholic fatty liver disease?","volume":"343","author":"Anstee","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2015.12.005_bb0015","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.005_bb0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.005_bb0025","first-page":"2355","article-title":"Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases","volume":"85","author":"Hofbauer","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.005_bb0030","first-page":"14","article-title":"Circulating osteoprotegerin and soluble RANKL: do they have a future in clinical practice?","volume":"28","author":"Dovio","year":"2005","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.metabol.2015.12.005_bb0035","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.12.005_bb0040","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.metabol.2010.11.002","article-title":"Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy","volume":"60","author":"Chang","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00365513.2010.524933","article-title":"Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease","volume":"70","author":"Yilmaz","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.metabol.2015.12.005_bb0055","doi-asserted-by":"crossref","first-page":"e0131664","DOI":"10.1371\/journal.pone.0131664","article-title":"Combined serum biomarkers in non-invasive diagnosis of non-alcoholic steatohepatitis","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.12.005_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/met.2013.0151","article-title":"The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease","volume":"12","author":"Ayaz","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.metabol.2015.12.005_bb0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s13105-013-0261-8","article-title":"The association of insulin resistance with serum osteoprotegerin in obese adolescents","volume":"69","author":"Suliburska","year":"2013","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.metabol.2015.12.005_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cyto.2008.07.471","article-title":"Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes","volume":"44","author":"Yaturu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.metabol.2015.12.005_bb0075","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.metabol.2009.09.019","article-title":"Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women","volume":"59","author":"Nabipour","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0080","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc08-S055","article-title":"Diagnosis and classification of diabetes mellitus","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.12.005_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2008.06.004","article-title":"Pathophysiological roles of osteoprotegerin (OPG)","volume":"88","author":"Reid","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.metabol.2015.12.005_bb0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2015.12.005_bb0100","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.12.005_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance","volume":"2","author":"Roden","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.005_bb0110","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","article-title":"The role of insulin resistance in nonalcoholic fatty liver disease","volume":"91","author":"Utzschneider","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.005_bb0115","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.3748\/wjg.v20.i36.12956","article-title":"Non-alcoholic fatty liver disease: what the clinician needs to know","volume":"20","author":"Machado","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.12.005_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/00365513.2011.570868","article-title":"Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes","volume":"71","author":"Altinova","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.metabol.2015.12.005_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-10-0875","article-title":"Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus","volume":"164","author":"Park","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2015.12.005_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.09.028","article-title":"Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome","volume":"91","author":"Akinci","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2015.12.005_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-07-0797","article-title":"Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study","volume":"158","author":"Gannag\u00e9-Yared","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2015.12.005_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.metabol.2012.06.005","article-title":"A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance","volume":"62","author":"O'Sullivan","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0145","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.metabol.2010.10.001","article-title":"Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects","volume":"60","author":"Ashley","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-10-0720","article-title":"Circulating osteoprotegerin and soluble receptor activator of nuclear factor \u03baB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction","volume":"164","author":"Pepene","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2015.12.005_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.arcmed.2007.04.013","article-title":"Circulating leptin and osteoprotegerin levels affect insulin resistance in healthy premenopausal obese women","volume":"38","author":"Ugur-Altun","year":"2007","journal-title":"Arch Med Res"},{"key":"10.1016\/j.metabol.2015.12.005_bb0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.metabol.2015.04.004","article-title":"Obesity-related changes in bone structural and material properties in hyperphagic OLETF rats and protection by voluntary wheel running","volume":"64","author":"Hinton","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00198-009-0990-2","article-title":"The relationship between low bone mass and metabolic syndrome in Korean women","volume":"21","author":"Hwang","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2015.12.005_bb0170","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11657-013-0142-3","article-title":"Low bone mineral density is associated with metabolic syndrome in South Korean men but not in women: the 2008\u20132010 Korean National Health and Nutrition Examination Survey","volume":"8","author":"Kim","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.metabol.2015.12.005_bb0175","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","article-title":"Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study","volume":"29","author":"Janghorbani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.12.005_bb0180","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.metabol.2013.05.004","article-title":"Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: insight into the BMD and bone fragility paradox","volume":"62","author":"Hamilton","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0185","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.metabol.2014.09.002","article-title":"Type 2 diabetes mellitus and fracture risk","volume":"63","author":"Dede","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0190","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","article-title":"Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.005_bb0195","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40618-015-0315-6","article-title":"Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?","volume":"38","author":"Targher","year":"2015","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.metabol.2015.12.005_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molmed.2013.05.006","article-title":"Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver","volume":"19","author":"Musso","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2015.12.005_bb0205","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.metabol.2013.07.007","article-title":"Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in mice","volume":"62","author":"Saraswathi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0210","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2015.07.011","article-title":"Novel therapies for osteoporosis","volume":"64","author":"Makras","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.12.005_bb0215","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:09:25Z","timestamp":1758427765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515003704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0026049515003704"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case\u2013control study in China","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}